Published February 3, 2021
| Version v1
Dataset
Open
Generation, characterization and drug sensitivities of twelve patient-derived IDH1 mutant glioma cell cultures
Authors/Creators
- 1. Department of Neurosurgery, Brain Tumor Center, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Zuid-Holland, 3015 GN, The Netherlands
- 2. Department of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Zuid-Holland, 3015 GN, The Netherlands
- 3. Department of Molecular Genetics, Erasmus University Medical Center, Rotterdam, Zuid-Holland, 3015 GN, The Netherlands
- 4. Department of Biology, Faculty of Natural Sciences, Universidad del Rosario, Bogotá, Colombia
- 5. Information Technologies for Translational Medicine (ITTM), Esch-Sur-Alzette, 4362, Luxembourg (RTCY)
- 6. Metabolic Unit, Department of Clinical Chemistry, Amsterdam University Medical Center, Noord-Holland, 1081 HV, The Netherlands
- 7. Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Zuid-Holland, 3015 GN, The Netherlands
Description
RNA-seq data of glioma samples and their matched primary cultures. Cultures were exposed to the IDH mutant-specific inhibitor AGI-5198 or DMSO control.